Clinicn Investigator, Full Prf DOM Endocrine Administration MGPO, Mass General Research Institute

Professor of Medicine Harvard Medical School

Distinguished Physician Metabolism, Massachusetts General Hospital

MD University of Rochester School of Medicine and Dentistry 1988

body composition; cardiovascular risk factors; ghrh; growth hormone-releasing hormone; growth-releasing hormone; hiv infections; hiv wasting syndrome; hiv-associated lipodystrophy syndrome; human growth hormone; lipodystrophy; obesity; visceral fat Dr. Grinspoon is a clinical researcher who studies the development of novel neuroendocrine strategies to reduce cardiovascular and metabolic risk associated with excess visceral fat, with a focus on the use of growth hormone releasing hormone (GHRH) to increase endogenous pulsatile GH, and selectively reduce visceral fat. His research interests include metabolic consequences of visceral fat accumulation in lipodystrophy and obesity.